Startseite
Impressum
Datenschutz
 
 
  SPOT ON
 

Who buys whom? When big pharma goes shopping …

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Endocarditis prophylaxis: from rule to exception

 
  a-t READER'S QUESTIONS AND COMMENTS
 

ACE inhibitors plus angiotensin II receptor antagonists: a reasonable combination?

Levothyroxine (e.g. EUTHYROX) in the morning or at night?

 
  QUALITY CONTROL
 

Quality comparison of bisoprolol (CONCOR, generics) tablets as well as lisinopril (ACERBON, generics) tablets

 
  IN BRIEF
 

Do proton pump inhibitors attenuate the effectiveness of acetylsalicylic acid?

Mefloquine (LARIAM) no longer for emergency self-treatment of malaria

EMA - oral preparations of the vasodilatator buflomedil (FUFEDIL, generics) should be withdrawn from the market

Umbrella brands: what is FENISTIL - an antiallergic, a corticoid, a virostatic or a medical device?

 
  BEWARE! MISSINFORMATION
 

Freeloader: promotion of PERENTEROL

 
  SIDE EFFECTS

Hearing impairment due to terbinafine (LAMISIL, generics)

 
  CURRENT ADR NETWORK REPORT
 

Allergy to indacaterol (ONBREZ BREEZHALER)

 
  e a-t IN THE INTERNET
 

Company guide: information supplementing the spot-on story

 
© arznei-telegramm 6/2011